Anteilseigner
Richard E. Uihlein (16,63 %) 10X Capital Management LLC (9,57 %) The Vanguard Group, Inc. (3,17 %) Osaic Wealth, Inc. (Investment Management) (2,04 %) James Carl Czirr (1,25 %) Kevin D. Freeman (1,20 %) BlackRock Fund Advisors (1,14 %) Geode Capital Management LLC (0,92 %) Kary Noel Eldred (0,78 %) Geneos Wealth Management, Inc. (0,66 %) Wealthspire Advisors LLC (0,64 %) Susquehanna Financial Group LLLP (0,58 %) Western International Securities, Inc. (0,35 %) Morgan Stanley Smith Barney LLC (Investment Management) (0,29 %) SSgA Funds Management, Inc. (0,26 %) Cambridge Investment Research Advisors, Inc. (0,20 %) Commonwealth Equity Services LLC (0,19 %) Cutter & Co. Brokerage, Inc. (Investment Management) (0,19 %) Northern Trust Investments, Inc.(Investment Management) (0,16 %)
Kontakt
Galectin Therapeutics Inc.
Suite 34, Wells Avenue 7
02459 Newton